Episode 18: Karen Petrou and David Brint - BioBonds

Episode 18 March 23, 2022 00:55:46
Episode 18: Karen Petrou and David Brint - BioBonds
Few & Far Between: How Biotech Gets Built
Episode 18: Karen Petrou and David Brint - BioBonds

Mar 23 2022 | 00:55:46

/

Show Notes

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

Other Episodes

Episode 22

July 26, 2022 00:23:58
Episode Cover

Episode 22: Dr. Jocelynn Pearl, Senior Scientist at Tune Therapeutics, Host of Lady Scientist Podcast

How can DAOs - Decentralized Autonomous Organizations - improve rare disease research? Biorasi's Few & Far Between Podcast welcomes Dr. Jocelynn Pearl, Senior Scientist...

Listen

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen

Episode 29

March 21, 2023 00:46:50
Episode Cover

Episode 29: Mika Newton, CEO at XCures

"We work with hundreds of patients a month, helping them understand their own medical history and then tracking what happens to them in the...

Listen